ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 215 out of 2035

$554K Total Retail Price of All Prescriptions

Rank: 250 out of 2035

476 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

33% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 5,478 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 599 215 S3 1 2
SIMVASTATIN 480 330 2 1
LISINOPRIL 379 232 3 3
OMEPRAZOLE 308 149 4 5
METFORMIN HCL 288 169 5 9
LEVOTHYROXINE SODIUM 261 156 6 4
ATENOLOL 203 143 7 10
METOPROLOL TARTRATE 196 133 8 8
AMLODIPINE BESYLATE 190 123 9 6
FUROSEMIDE 168 108 10 7
WARFARIN SODIUM 158 85 11 11
LOSARTAN POTASSIUM 144 118 12 15
RANITIDINE HCL 144 72 12 28
ZOLPIDEM TARTRATE 133 64 14 21
HYDROCHLOROTHIAZIDE 127 103 15 12
GABAPENTIN 118 56 16 14
IBUPROFEN 116 56 17 43
CYCLOBENZAPRINE HCL 112 46 R 18 64
PROAIR HFA 107 43 19 31
ISOSORBIDE MONONITRATE ER 106 78 20 32
AMITRIPTYLINE HCL 100 68 R 21 101
PRAVASTATIN SODIUM 98 52 22 17
ACETAMINOPHEN-CODEINE 95 49 S3 23 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 53 24 26
CITALOPRAM HBR 80 43 25 20
CARVEDILOL 79 34 26 22
ALENDRONATE SODIUM 73 53 27 27
LANTUS SOLOSTAR 72 63 28 66
ATORVASTATIN CALCIUM 72 40 28 13
METOPROLOL SUCCINATE 71 45 30 16
FLUTICASONE PROPIONATE 68 42 31 29
TAMSULOSIN HCL 67 43 32 25
CLOPIDOGREL 65 44 33 30
CARISOPRODOL 63 0 R 34 57
LEVEMIR FLEXPEN 61 56 35 204
VITAMIN D2 56 52 36 353
HYDRALAZINE HCL 53 43 37 45
NAPROXEN 53 32 37 92
ADVAIR DISKUS 52 26 39 38
GLYBURIDE 51 22 R 40 74
LOVASTATIN 51 21 40 33
TRAMADOL HCL 50 22 42 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.